Figure 2.

Patient and death-censored allograft survival for recipients aged ≥65 years who received transplantation from a deceased donor aged ≥65 years in the ESP and the United States. The shaded area represents the difference between patient and death-censored allograft survival. ESP recipients were more likely to outlive their transplant requiring them to return to dialysis for an average of 5.2 months over the 5-year follow-up period. Among United States recipients, the death-censored allograft survival exceeded patient survival by 9.6 months, indicating that on average, elderly United States recipients aged ≥65 years die with a functioning allograft after ECD transplantation.